Search by Drug Name or NDC

    NDC 62756-0723-60 AfterPlan 1.5 mg/1 Details

    AfterPlan 1.5 mg/1

    AfterPlan is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by SUN PHARMACEUTICAL INDUSTRIES, INC.. The primary component is LEVONORGESTREL.

    Product Information

    NDC 62756-0723
    Product ID 62756-723_f86715c5-932d-405d-b81d-286c86409b1e
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name AfterPlan
    Proprietary Name Suffix n/a
    Non-Proprietary Name levonorgestrel
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 1.5
    Active Ingredient Units mg/1
    Substance Name LEVONORGESTREL
    Labeler Name SUN PHARMACEUTICAL INDUSTRIES, INC.
    Pharmaceutical Class Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA202635
    Listing Certified Through 2024-12-31

    Package

    NDC 62756-0723-60 (62756072360)

    NDC Package Code 62756-723-60
    Billing NDC 62756072360
    Package 1 BLISTER PACK in 1 CARTON (62756-723-60) / 1 TABLET in 1 BLISTER PACK
    Marketing Start Date 2017-05-12
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL c30c7bc2-04fa-4590-96f5-5bcf4bba3f1a Details

    Revised: 10/2018